ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $114,000 | -57.8% | 22,771 | +1.5% | 0.00% | – |
| Q3 2021 | $270,000 | +24.4% | 22,425 | +119.0% | 0.00% | – |
| Q2 2021 | $217,000 | -18.1% | 10,241 | +8.3% | 0.00% | – |
| Q1 2021 | $265,000 | -71.7% | 9,457 | -73.8% | 0.00% | -100.0% |
| Q4 2020 | $938,000 | +68.1% | 36,091 | +140.2% | 0.00% | 0.0% |
| Q3 2020 | $558,000 | +151.4% | 15,024 | +247.4% | 0.00% | – |
| Q2 2020 | $222,000 | -51.8% | 4,325 | -53.0% | 0.00% | -100.0% |
| Q3 2017 | $461,000 | +2.9% | 9,205 | -4.8% | 0.00% | 0.0% |
| Q2 2017 | $448,000 | -37.2% | 9,673 | -52.1% | 0.00% | -50.0% |
| Q1 2017 | $713,000 | – | 20,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |